Navigation Links
Small Implant To Check On Cancer

Scientists from US are refining measures to use microscopic particles that will stick to chemicals in cancer cells// and will show up during scans. This technique is yet to be tested on humans. These implants could let the doctor know about the extent of spread of cancer cells and the effect of drugs on them.

The current procedure of scans and blood test do not highlight the extent of drug penetration in to the tumor. For doctors, it is an uphill task to find out about the appropriate dose of a cancer drug or its efficacy.

Microscopic nanoparticles made out of iron oxide and coated with a sugar called dextran are being used in the project undertaken by a team from Massachusetts Institute of Technology (MIT). These tiny particles are coated with antibodies, immune system components which can attach itself to specific molecules inside cancer cells. These particles cluster together whenever the target molecules are present which can be spotted while MRI scanning.

The tiny silicon container that houses the nanoparticles are important as it permits the chemical reaction to take place without nanoparticles getting dispersed out of the cancer tumor. This enables the doctor to have long term and detailed view of cancer conditions. Currently the team is perfecting a few tests which can be tried out in humans. The team is optimistic that the particles can be grouped together by human chorionic gonadotrophin, which is a hormone produced by few cancers and in pregnant women.

Cancer Research UK medical director Professor John Toy while welcoming these tests said that there is a long way for such tests to reach its desirable results.


JYT
'"/>




Page: 1

Related medicine news :

1. Smallpox as Biological Weapons?
2. Is Smallpox Threat Real ?
3. Smallpox Vaccine May Help Fight Cervical Cancer
4. Smallpox Would Spread Rapidly
5. Drug Firm Offers to Donate Smallpox Vaccine
6. Small aneurysms best left untouched
7. Small lumps in breast if not treated may cause long-term harm
8. Third generation Small pox vaccine from Cell-culture
9. CT Scans Said to Accurately Detect Small Cancers
10. Brain of Cocaine Addicts Smaller In Size
11. Researchers Begin Study To Find Out If Angioplasty Can Be Safely Done In Smaller Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... ... December 06, 2016 , ... Individuals who seek to ... as drinking more water or limiting their exposure to the sun, according to a ... beauty group Beverly Hills Physicians (BHP) notes that, while preventive measures to help keep ...
(Date:12/6/2016)... ... December 06, 2016 , ... An inventor, from Talladega, Ala., thought there ... she invented the patent-pending SLING-VEST. , The SLING-VEST provides an effective way to support ... to traditional slings. As a result, it helps to reduce discomfort and shifting. The ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... health insights for population health management, announces today a strategic relationship with ... CitiusTech’s cloud-hosted clinical rules engine that offers advanced Clinical Quality Measures (CQM) ...
(Date:12/6/2016)... ... December 06, 2016 , ... It ... Women’s Magazine inaugural Maine Women’s Expo. Hundreds of women gathered to check out ... resource. The expo’s beneficiary this year was Crossroads, a fully-accredited gender-responsive treatment ...
(Date:12/6/2016)... ... December 06, 2016 , ... The Touchpoint Solution’s new ... after launch. Almost 200 backers pledged more than $25,000 on Kickstarter ... , Dr. Amy Serin, an Arizona Neuropsychologist and inventor, says she feels like ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... SAN DIEGO , Dec. 6, 2016 /PRNewswire/ ... leading RNA medicines company, announced today that it ... to develop RNA-based therapeutics for the treatment of ... Arcturus, wholly-owned therapeutic delivery platform LUNAR™ and UNA ... "Given Takeda,s long-standing commitment to and ...
(Date:12/6/2016)... 6, 2016  Regulus Therapeutics Inc. (NASDAQ: ... discovery and development of innovative medicines targeting microRNAs, ... its R&D day, held in New ... an anti-miR targeting microRNA-27 (miR-27) for the treatment ... an anti-miR targeting microRNA-17 (miR-17) for the treatment ...
(Date:12/6/2016)... , Dec. 6, 2016 A new study ... 340B (AIR 340B) projects the 340B Drug Pricing Program will ... which time it is expected to exceed $23 billion in ... see 340B purchases surpass current Medicare Part B drug reimbursement ... new study – based on analysis of data on total ...
Breaking Medicine Technology: